| Factor Information | |
|---|---|
| Data ID | 1338 |
| Factor | No therapy delivered (shock or ATP) |
| Description | Number of zones in ICD programme |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To access the outcome of ICD according to programming |
| p Value | 0.0014 |
| Conclusion | Most patients had ICD for secondary prevention (62%). There was a 2.9% annual appropriate shock rate. The risks and benefits of ICD implantation are patient and disease specific, and must be clearly discussed prior to implantation. Further research is warranted into the use of primary prevention ICD in ACHD and in alternatives to ICD such as ablation in specific patient groups. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 519 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/TGA/ASD/PDA/EA/DORV/DCRV/DILV/TA/VSD, RVOTO/PDA, VSD |
| Reference | |
|---|---|
| PMID | 27234868 |
| Year | 2016 |
| Title | Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | ||
| Region | Birmingham, UK | |
| Method | N/A | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | undergoing ICD implant | |
| Group | More than one zone(Treatment) | one zone(Control) |
| Number | 4(total:16) | 15(total:18) |
| Age | 45 (21–71) years. | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 4 | 15 |
